Buclosamide

This classification denotes an antifungal agent with the molecular formula C11H14ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O52NM0A9YL, chemically known as benzamide, n-butyl-4-chloro-2-hydroxy- but generally known as buclosamide, which bears US NIH Compound Identifier 68466. European Medicines Agency schedules Buclosamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05948MIG. The term BUCLOSAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). BUCLOSAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buclosamide under HS 29242995 and SITC 51479. As of Q4 2014, BUCLOSAMIDE remains the US FDA Preferred Term for this commodity. Buclosamide bears US NLM identifiers UMLS ID C0162967 and NCI Concept Code C72958. SMILES: CCCCNC(=O)C1=C(C=C(C=C1)CL)O.